The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset
- PMID: 20522809
- PMCID: PMC2909671
- DOI: 10.1161/STROKEAHA.110.583815
The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset
Abstract
Background and purpose: The benefit of intravenous thrombolytic therapy in acute brain ischemia is strongly time dependent.
Methods: The Get With the Guidelines-Stroke database was analyzed to characterize ischemic stroke patients arriving at hospital Emergency Departments within 60 minutes of the last known well time from April 1, 2003, to December 30, 2007.
Results: During the 4.75-year study period, among 253 148 ischemic stroke patients arriving directly by ambulance or private vehicle at 905 hospital Emergency Departments, 106 924 (42.2%) had documented, exact last known well times. Onset to door time was <or=60 minutes in 30 220 (28.3%), 61 to 180 minutes in 33 858 (31.7%), and >180 minutes in 42 846 (40.1%). Features most strongly distinguishing the patients arriving at <or=60, 61 to 180, and >180 minutes were greater stroke severity (median National Institutes of Health Stroke Scale score, 8.0 vs 6.0 vs 4.0, P<0.0001) and more frequent arrival by ambulance (79.0%. vs 72.2% vs 55.0%, P<0.0001). Compared with patients arriving at 61 to 180 minute, "golden hour" patients received intravenous thrombolytic therapy more frequently (27.1% vs 12.9%; odds ratio=2.51; 95% CI, 2.41-2.61; P<0.0001), but door-to-needle time was longer (mean, 90.6 vs 76.7 minutes, P<0.0001). A door-to-needle time of <or=60 minutes was achieved in 18.3% of golden hour patients.
Conclusions: At Get With the Guidelines-Stroke hospital Emergency Departments, more than one quarter of patients with documented onset time and at least one eighth of all ischemic stroke patients arrived within 1 hour of onset, where they received thrombolytic therapy more frequently but more slowly than late arrivers. These findings support public health initiates to increase early presentation and shorten door-to-needle times in patients arriving within the golden hour.
Conflict of interest statement
Dr. Smith receives research support from the NIH (NINDS R01 NS062028) the Canadian Stroke Network, and the Hotchkiss Brain Institute and Canadian Institutes for Health Research, and salary support from the Canadian Institutes for Health Research.
Dr. Fonarow receives research support from the National Institutes of Health (significant), serves as a consultant to Pfizer, Merck, Schering Plough, Bristol Myers Squibb, and Sanofi-Aventis (all modest); receives speaker honoraria from Pfizer, Merck, Schering Plough, Bristol Myers Squibb, and Sanofi-Aventis (all significant); and is an employee of the University of California, which holds a patent on retriever devices for stroke.
Dr. Reeves receives salary support from the Michigan Stroke Registry
Dr. Zhao is a member of the Duke Clinical Research Institute which serves as the AHA GWTG data coordinating center.
Dr. Olson is a member of the Duke Clinical Research Institute which serves as the AHA GWTG data coordinating center.
Dr. Schwamm serves as a consultant to the Research Triangle Institute, CryoCath, and to the Massachusetts Department of Public Health.
Figures


Similar articles
-
Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.JAMA. 2020 Jun 2;323(21):2170-2184. doi: 10.1001/jama.2020.5697. JAMA. 2020. PMID: 32484532 Free PMC article.
-
Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.Cerebrovasc Dis. 2012;34(5-6):400-5. doi: 10.1159/000343504. Epub 2012 Dec 4. Cerebrovasc Dis. 2012. PMID: 23221276
-
Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):514-22. doi: 10.1161/CIRCOUTCOMES.112.965210. Epub 2012 Jul 10. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22787065
-
Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.JAMA Neurol. 2014 Sep;71(9):1155-61. doi: 10.1001/jamaneurol.2014.1528. JAMA Neurol. 2014. PMID: 25023407
-
Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke.Stroke. 2017 Apr;48(4):946-954. doi: 10.1161/STROKEAHA.116.015712. Epub 2017 Feb 22. Stroke. 2017. PMID: 28228574
Cited by
-
Reducing door-to-needle times using Toyota's lean manufacturing principles and value stream analysis.Stroke. 2012 Dec;43(12):3395-8. doi: 10.1161/STROKEAHA.112.670687. Epub 2012 Nov 8. Stroke. 2012. PMID: 23138440 Free PMC article.
-
Impact of COVID-19 on Emergency Medical Services for Patients with Acute Stroke Presentation in Busan, South Korea.J Clin Med. 2021 Dec 24;11(1):94. doi: 10.3390/jcm11010094. J Clin Med. 2021. PMID: 35011835 Free PMC article.
-
Increased recurrent risk did not improve cerebrovascular disease survivors' response to stroke in China: a cross-sectional, community-based study.BMC Neurol. 2020 Apr 21;20(1):147. doi: 10.1186/s12883-020-01724-1. BMC Neurol. 2020. PMID: 32316929 Free PMC article.
-
Point-of-Care Assessment of Direct Oral Anticoagulation in Acute Ischemic Stroke: Protocol for a Prospective Observational Diagnostic Accuracy Study.Thromb Haemost. 2022 Nov;122(11):1954-1962. doi: 10.1055/a-1869-7853. Epub 2022 Jun 7. Thromb Haemost. 2022. PMID: 35672013 Free PMC article.
-
Reasons for low thrombolysis rate in a Norwegian ischemic stroke population.Neurol Sci. 2014 Dec;35(12):1977-82. doi: 10.1007/s10072-014-1876-4. Epub 2014 Jul 17. Neurol Sci. 2014. PMID: 25030125
References
-
- Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–1329. - PubMed
-
- Saver JL. Time is brain--quantified. Stroke. 2006;37:263–266. - PubMed
-
- Marler JR, Winters Jones P, Emr M. The National Institute of Neurological Disorders and Stroke: Proceedings of National Symposium on Rapid Identification and Treatment of Acute Stroke; Bethesda, MD. 1997.
-
- Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275–282. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous